RESET THERAPEUTICS

Details for Australian Trade Mark No. 1338666 (hide)

Owner Reset Therapeutics, Inc.

Convention US 4 June 2009 77752603

Various Convention priority claimed: 4 June 2009, United States of America, No. 77752603 in respect of PHARMACEUTICAL DRUGS AND THERAPEUTICS FOR ADJUSTMENT OF THE HUMAN BODY'S CIRCADIAN RHYTHMS AND FOR TREATMENT OF CIRCADIAN RHYTHM METABOLISM, CIRCADIAN RHYTHM DI

Filing Date 2 December 2009

Classes

Class 5 Pharmaceutical drugs and therapeutics for adjustment of the human body's circadian rhythms and for treatment of circadian rhythm metabolism, circadian rhythm disturbances and dysfunction, and associated metabolic disorders

Class 42 Pharmaceutical drug and therapeutics research and development services, namely, providing screening platforms and technologies for characterization and testing of compounds for their impact on the human body's circadian rhythms and circadian activity and for development of pharmaceutical drugs and therapeutics for treatment of circadian rhythm metabolism, circadian rhythm disturbances and dysfunction, and associated metabolic disorders

Event Publications

21 January 2010 Application filed

11 February 2010 Application Accepted

3 June 2010 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1338667

1338665-3D-SCULPT